scispace - formally typeset
Open AccessJournal Article

Risk factors for multi-drug resistant tuberculosis in patients at tertiary care hospital, Peshawar.

TLDR
The most common factors in the study group were previous history of tuberculosis, repeated courses of ATT, prescribed by different clinicians and unsupervised treatment by a GP during the initial course of ATT.
Abstract
Objective To determine the frequency of common risk factors for multi-drug resistant tuberculosis in patients presented at a tertiary care hospital, Peshawar. Study design Cross-sectional, observational study. Place and duration of study Pulmonology Department, Khyber Teaching Hospital, Peshawar, from December 2006 to October 2007. Methodology Patients with positive AFB culture and sensitivity results and found resistant to both rifampicin and isoniazid with or with resistance to other first line anti-tuberculosis drugs, were recruited from both Pulmonology Ward and Outpatient Department (OPD). Informed verbal consent was taken and a questionnaire administered to all participants of the study. Information regarding demographics, education status, occupation, monthly household income, AFB C/S, details of past history of tuberculosis and family history of TB or Multi-Drug Resistant (MDR-TB) was recorded. Data was analyzed on SPSS version 11. Results A total of 30 patients of MDR-TB were interviewed. Male (n=17) and female (n=13) ratio was 1.3:1. Mean age was 34.2+/-15.3 years. Ninety-two percent female and 52.9% male were uneducated. In 56.7%, monthly income was less than 5,000 rupees and in 40% between 5,000-10,000 rupees. All patients had previous history of Antituberculous Treatment (ATT), in which 20% had undertaken ATT course once, 53.3% twice and 26.7% thrice in the past. In the study group, 13 (43.3%) patients had not completed their first ATT course and 11 of them were receiving ATT from a general practitioner (GP) at that time. Seven (23.3%) patients had family history of TB but no one had documented MDR-TB in the family. Resistance to RH was present in all patients; moreover, 56.7% had resistance to RHEZ+S. Conclusion The most common factors in the study group were previous history of tuberculosis, repeated courses of ATT, prescribed by different clinicians and unsupervised treatment by a GP during the initial course of ATT.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.

TL;DR: TB treatment failure, cavitation on chest X-ray, contact with MDR-TB patients and low socioeconomic status were important risk factors for development of MDR -TB.
Journal ArticleDOI

Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia.

TL;DR: The rate of MDR-TB was high among suspected cases in the Oromia Region of Ethiopia, and an occupation of farming, known TB contact history, alcohol use, HIV infection, previous known TB history, and previous TB treatment outcome were predictors of MDST.
Journal ArticleDOI

Molecular detection of genes related to biofilm formation in multidrug-resistant Acinetobacter baumannii isolated from clinical settings.

TL;DR: It was shown that all double-negative bap/blaPER-1 isolates were recovered from the bloodstream and had low biofilm formation capabilities, and mostly belonged to type D wrinkled colony morphology, however, clinical isolates extracted from the throats of patients were blaper-1-positive and had a great capacity to form biofilm, and also mostly belongedto type C wrinkled colonies morphology.
Journal Article

Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan.

TL;DR: There is a need to fully implement national tuberculosis guidelines with a focus on expansion and effective implementation of directly observed therapy short course in order to prevent further emergence of drug resistance.
References
More filters

Global tuberculosis control: surveillance planning financing. WHO report 2003.

TL;DR: In this paper, the authors argue that if the current rate of DOTS expansion in maintained the 70% detection target will not be reached by 2005, if that target is ever to be reached DOTS programmes must improve case finding within designated DOTS areas and must expand to new areas.
Journal ArticleDOI

Risk factors for multidrug resistant tuberculosis in Europe: a systematic review

TL;DR: Previous treatment was the strongest determinant of MDR-TB in Europe, and the risk of MDA in foreign born people needs to be re-evaluated, taking into account any previous treatment.

Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO / IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007.

TL;DR: This report includes new data from 77 settings or countries collected in the third phase of the project between 1999 and 2002 representing 20% of the global total of new smear-positive TB cases and reports trends for 46 settings.
Journal ArticleDOI

Criteria for the control of drug-resistant tuberculosis

TL;DR: It is shown that best-practice short-course chemotherapy is highly likely to bring strains resistant to either of the two key drugs isoniazid and rifampicin under control and to prevent the emergence of multidrug-resistant tuberculosis (MDR-TB).
Journal ArticleDOI

Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment

TL;DR: There should be a strong suspicion of drug resistance, including MDR-TB, in persons with a history of prior treatment or in treatment failure cases, and the diagnosis depends on confirming the drug susceptibility pattern of isolated organisms, which is often only possible in resource-rich settings.